Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1340.24	464.85	32.28
Graham Fair Price	167.08	7.81	2.93
PEG	-99.99	< 0.005	52.36
Price/Book	-49.77	1.22	2.43
Price/Cash Flow	139.96	-177.75	74.07
Prices/Earnings	94.04	-3.39	-56.92
Price/Sales	-58.90	0.55	1.33
Price/FCF	139.96	-177.75	74.07
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.56	0.62	0.61
Operating Margin	288.37	-0.04	0.01
ROA	-723.90	-0.03	< 0.005
ROE	-0.01	-0.09	-743.45
ROIC	-0.01	-0.07	-439.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.77	3.33	-76.83
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.66	-5.33	100.52
EPS QOQ	0.01	-6.69	61469.23
FCF QOQ	4.15	-1.19	-71.33
Revenue QOQ	0.03	0.12	278.46
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	27.27	28.55	4.68
Days Sales Outstanding (DSO)	2.56	0.75	-70.85
Inventory Turnover	3.30	3.15	-4.47
Debt/Capitalization	0.21	0.22	6.25
Quick Ratio	0.56	0.42	-24.25
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.97	5.49	-8.04
Cash	2.66	2.29	-14.12
Capex	-0.41	-0.24	40.83
Free Cash Flow	0.20	-0.04	-80.75
Revenue	10.86	12.21	12.40
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.90	0.81	-10.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.18	-103.95	3164.70
Naive Interpretation	Member

06 - Financial Health · Bad

Rating